AlEnizi Ahmad, AlSaeid Khaled, Alawadhi Adel, Hasan Eiman, Husain Entesar H, AlFadhli Ahmad, Ghanem Aqeel, Abutiban Fatemah, Ali Yaser, Al-Herz Adeeba, Mohammed Khuloud, Alkandari Waleed, Aldei Ali, Alhajeri Hebah, Dehrab Ahmad, Hayat Sawsan
Al Jahra Hospital, Al Jahra, Kuwait.
Faculty of Medicine, Kuwait University, Kuwait City, Kuwait.
Int J Rheumatol. 2018 May 13;2018:5217461. doi: 10.1155/2018/5217461. eCollection 2018.
People with IRD are at increased risk of infection, and in 2011 EULAR made general recommendations for vaccination in these patients. Global and European perspectives are important, but they cannot accurately reflect the individual situations of patients in different countries and regions. Based on our clinical experience and opinions, we have sought to tailor the original EULAR recommendations to include advice for vaccination with new agents approved in the intervening years-including the new class of targeted synthetic disease-modifying antirheumatic drugs. We have also considered the specific demographic needs of patients in local populations in the Gulf region. The resulting 16 recommendations are grouped into four main categories covering general vaccination guidelines and best-practice for all patients with IRD, followed by a set of recommended vaccines against specific pathogens. The last two categories include recommendations for certain patient subgroups with defined risks and for patients who wish to travel.
患有IRD的人感染风险增加，2011年欧洲抗风湿病联盟（EULAR）针对这些患者的疫苗接种提出了一般性建议。全球和欧洲的观点很重要，但它们无法准确反映不同国家和地区患者的个体情况。基于我们的临床经验和观点，我们试图调整EULAR的原始建议，纳入对这些年间获批的新药物（包括新型靶向合成抗风湿药物）进行疫苗接种的建议。我们还考虑了海湾地区当地人群中患者的特定人口统计学需求。由此得出的16项建议分为四大类，涵盖所有IRD患者的一般疫苗接种指南和最佳实践，随后是一组针对特定病原体的推荐疫苗。最后两类包括针对具有特定风险的某些患者亚组以及希望出行的患者的建议。
